Open house Arzneimittelrabattverträge Flecainid, ATC C01BC04

The work

Non-exclusive discount agreements for the active substance Flecainid (ATC C01BC04) to be concluded with all interested pharmaceutical companies meeting eligibility criteria under an open-house model.

• Identical and non-negotiable discount agreements
• Contract start date is the first of the following month if documents are complete and correct by the 3rd of the current month
• Contracts can be terminated with one month's notice to the end of a month
• Open-house agreements are automatically superseded by any national or state-level discount contracts for the same substance

Key facts

Contract period

From 01.02.2026 to 31.01.2028

Evaluation

This is an open-house model, not a competitive tender. All eligible companies that submit the required documents are accepted as contract partners.

What it takes to qualify

Documents to submit

1. ausgefüllte und unterzeichnete Eigenerklärung zur Zuverlässigkeitmust be signed and include proof of representational authority from trade register extract or power of attorney
2. ausgefüllter und unterzeichneter Vertragmust be signed in writing or with qualified electronic signature
3. ausgefüllte und unterzeichnete Anlage 'Festlegung der vertragsgegenständlichen Arzneimittel'must be signed in writing or with qualified electronic signature
4. Handelsregisterauszugrequired if not evident from other documents to prove representational authority
5. Vollmachtrequired if not evident from other documents to prove representational authority